Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Merck Committed to Cubist After Patent Loss

December 9, 2014 3:06 pm | by Tom Murphy - AP Business Writer | News | Comments

Shares of both companies tumbled Tuesday morning in the first day of trading. Read more...                             


Genetic Errors Linked to Aging Can Make Leukemia Appear After Treatment

December 9, 2014 1:23 pm | by Caroline Arbanas, Washington University in St. Louis | News | Comments

Treatment aimed at curing cancer can lead to a form of leukemia with a poor prognosis. Read more...                          


Vaccine May Prevent Antibiotic Resistant Skin Infections

December 9, 2014 1:15 pm | News | Comments

Treatment is difficult because MRSA is resistant to many antibiotics, and the infections can recur, placing family members and other close contacts at risk of infection. Read more....             


Report Shows Doctors Prescribing Fewer Opioids for Pain

December 9, 2014 1:06 pm | by John Hopkins School of Public Health | News | Comments

Nine in 10 primary care physicians say that prescription drug abuse is a moderate or big problem in their communities. Read more...                      


Startup Aims to Develop 100 Drugs in 10 Years

December 9, 2014 12:59 pm | by University of Utah | News | Comments

A start-up wants to quickly and affordably identify unexpected ways a drug could be used by testing it on diseased cells. Read more...                     


New Analytics Tool Helps Hospitals Improve Antibiotic Usage

December 9, 2014 12:15 pm | News | Comments

Cardinal Health introduced a powerful new tool that gives pharmacists the ability to rapidly analyze antibiotic use trends. Read more...                     


Parkinson's Vaccine Being Tested on Patients in Europe

December 9, 2014 9:24 am | News | Comments

This vaccine is one out of a designated pool of promising vaccine candidates. Read more...                             


Trial Launched to Evaluate Amgen and Merck's Melanoma Treatment

December 9, 2014 9:04 am | News | Comments

Amgen announced the initiation of a trial of a new melanoma treatment. Read more...                              


Scientists Make Breakthrough in Understanding Rare Blood Cancer

December 9, 2014 8:51 am | by University of Southampton | News | Comments

A breakthrough in understanding of a rare form of blood cancer could lead to significant improvements in treatment for patients. Read more...                    


AbbVie Announces Phase 2 Results for AML Treatment

December 8, 2014 3:07 pm | News | Comments

AbbVie presented new results from a Phase 2 study of a treatment for AML at the American Society of Hematology's 56th Annual Meeting. Read more...                   


Bad Data Adds Another Problem to Ebola Outbreak

December 8, 2014 2:50 pm | by Maria Cheng and Sarah Dilorenzo - Associated Press | News | Comments

Having accurate numbers about the Ebola outbreak is essential not only to provide a realistic picture of the epidemic, but to determine effective control strategies. Read more...            


A Pill to Shed Fat?

December 8, 2014 2:36 pm | by B.D. Colen, Harvard University | News | Comments

Researchers created a system using human stem cells to screen for compounds that have the potential to turn white fat cells into brown fat cells. Read more...             


Tasigna Wins Over Gleevec in Ph+CML Patients

December 8, 2014 1:45 pm | News | Comments

Six-year results from Novartis' randomized Phase 3 study continue to demonstrate the superiority of Tasigna compared to Glivec. Read more...                   


New Agent Shrinks Small Cell Lung Tumors in Pre-Clinical Testing

December 8, 2014 1:20 pm | News | Comments

Researchers found that a new agent can disable the basic part of a tumor cell's survival mechanism. Read more...                         


New Immunotherapy Breakthrough Discovered

December 8, 2014 1:06 pm | by Robert Levy, Harvard Medical School | News | Comments

A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma into complete or partial remission. Read more...                     



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.